Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident HCV-Related Hepatocellular Carcinoma in Men

    May 2019 in “ Gastroenterology ”
    Donna L. White, Peter J. Richardson, Israel C. Christie, Sarah Plew, Li Jiao, Hashem B. El-Serag, Fasiha Kanwal, Jennifer R. Kramer
    Image of study
    TLDR Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.
    This document contains abstracts from several studies presented at a scientific conference. One study found that screening for hepatitis C virus (HCV) in an urban emergency department was effective in identifying infected patients, with a high rate of treatment and cure achieved through referral to a hepatology clinic. Another study found that there is modest concordance among non-invasive serum indices and imaging in HCV-related fibrosis, with lower BMI predicting agreement among non-invasive methods. A third study found that the use of androgen lowering medications finasteride and dutasteride does not substantially alter the risk of incident HCV-related hepatocellular carcinoma in men. Finally, a fourth study found that the albumin-bilirubin score can indicate liver fibrosis staging and prognosis in Japanese HCV infection patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Why is everyone not directly advised Dutasteride?

      in Finasteride/Dutasteride  165 upvotes 1 month ago
      Dutasteride is less commonly prescribed for hair loss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.

      community Is DUT better or worse than FIN?

      in Finasteride/Dutasteride  62 upvotes 1 year ago
      The conversation discusses the effectiveness of Dutasteride (DUT) and Finasteride (FIN) for hair loss. Users share varied experiences, with some finding DUT more effective and others experiencing side effects or no change, highlighting that individual responses can vary.

      community Fin/Min/VitD 3 month progress pics

       118 upvotes 5 years ago
      A user shared their positive 3-month experience using finasteride, minoxidil, and vitamin D to treat hair loss, noting significant regrowth and minimal shedding. They also discussed potential side effects and the low likelihood of experiencing them, while being open to answering further questions.

      community Are the japanese Finasteride 10 year studies even relevant to caucasian men - especially young ones?

      in Technology  105 upvotes 1 year ago
      The conversation is about the effectiveness of hair loss treatments, specifically finasteride and dutasteride, in different populations. Some users believe that the results of Japanese studies may not be relevant to Caucasian men, especially young ones, and that East Asians may respond better to these treatments. Others argue that clinical studies should be the basis for decision-making, while acknowledging that individual responses to medications can vary.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Related Research

    9 / 9 results